Applied Therapeutics estimates equity at ~$17.4M; applies to transfer Nasdaq listing

Applied Therapeutics, Inc.

Preliminary unaudited total stockholders' equity as of June 30, 2025 estimated at $17.4 million.
Received Nasdaq bid price deficiency notice in Feb 2025; 180-day cure period ended Aug 6, 2025.
Applied to transfer listing from Nasdaq Global Market to Nasdaq Capital Market; believes it meets all standards except bid price.
Nasdaq has not yet granted the application; delisting risk remains if transfer is not approved.

item 2.02item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.